01 / Vendor Profile
ADVANCED CELL DIAGNOSTICS, INC. Federal Contracts and Awards
UEI UD6XW8DAGLK6 · CAGE 4FBA8
Federal contract activity attributed to this vendor identity across FY 2020–FY 2026. Obligations are FPDS accounting transactions, not company revenue.
02 / Federal Business Size
Federal contract market at a glance
Measured consistently across FY 2020–FY 2026.
Across FY 2020–FY 2026, FPDS records attribute $2.12M in net contract obligations to ADVANCED CELL DIAGNOSTICS, INC. across 102 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.
03 / Spending Trend
ADVANCED CELL DIAGNOSTICS, INC. contract spending by year
Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.
Total obligations$399.5K
FY 2026ObligationsHistorical spending range
| Fiscal year | Obligations | Actions | Federal customers | Change |
|---|---|---|---|---|
| FY 2020 | $224.1K | 15 | 2 | — |
| FY 2021 | $339.0K | 15 | 2 | +51.2% |
| FY 2022 | $315.3K | 14 | 2 | −7.0% |
| FY 2023 | $529.5K | 27 | 3 | +67.9% |
| FY 2024 | $192.8K | 16 | 2 | −63.6% |
| FY 2025 | $123.1K | 9 | 2 | −36.1% |
| FY 2026 | $399.5K | 6 | 3 | +224.4% |
04 / Federal Customers
Which federal agencies buy from ADVANCED CELL DIAGNOSTICS, INC.?
Ranked by net obligations during FY 2020–FY 2026.
| Agency | Code | Obligations | Actions | Vendor share |
|---|---|---|---|---|
| 7529 | $1.99M | 91 | 93.8% | |
| 3600 | $71.1K | 7 | 3.4% | |
| 7523 | $48.9K | 2 | 2.3% | |
| 12K3 | $13.0K | 1 | 0.6% | |
| 7524 | -$2.1K | 1 | -0.1% |
05 / Contracting Offices
Which contracting offices buy from ADVANCED CELL DIAGNOSTICS, INC.?
Ranked by net obligations during FY 2020–FY 2026.
| Office | Code | Agency | Obligations | Actions | Vendor share |
|---|---|---|---|---|---|
| 75N980 | NATIONAL INSTITUTES OF HEALTH | $532.7K | 9 | 25.1% | |
| 75N950 | NATIONAL INSTITUTES OF HEALTH | $314.3K | 14 | 14.8% | |
| 75N930 | NATIONAL INSTITUTES OF HEALTH | $290.9K | 17 | 13.7% | |
| 75N900 | NATIONAL INSTITUTES OF HEALTH | $286.5K | 10 | 13.5% | |
| 75N940 | NATIONAL INSTITUTES OF HEALTH | $140.8K | 13 | 6.6% | |
| 75N910 | NATIONAL INSTITUTES OF HEALTH | $129.3K | 10 | 6.1% | |
| 75N92C | NATIONAL INSTITUTES OF HEALTH | $89.4K | 7 | 4.2% | |
| 75N98C | NATIONAL INSTITUTES OF HEALTH | $86.2K | 4 | 4.1% | |
| 75N920 | NATIONAL INSTITUTES OF HEALTH | $78.5K | 4 | 3.7% | |
| 75D301 | CENTERS FOR DISEASE CONTROL AND PREVENTION | $48.9K | 2 | 2.3% |
06 / Top NAICS Industries
Which industries define this vendor’s federal work?
| NAICS | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 334516 | ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING | $567.0K | 12 | 3 | 26.7% |
| 325413 | IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING | $482.4K | 27 | 1 | 22.7% |
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | $413.6K | 27 | 2 | 19.5% |
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | $215.3K | 13 | 1 | 10.1% |
| 541380 | TESTING LABORATORIES AND SERVICES | $195.3K | 8 | 1 | 9.2% |
| 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | $158.2K | 9 | 2 | 7.5% |
| 325998 | ALL OTHER MISCELLANEOUS CHEMICAL PRODUCT AND PREPARATION MANUFACTURING | $50.1K | 2 | 1 | 2.4% |
| 334519 | OTHER MEASURING AND CONTROLLING DEVICE MANUFACTURING | $26.9K | 1 | 1 | 1.3% |
| 339112 | SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING | $16.6K | 1 | 1 | 0.8% |
| 424210 | DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS | -$0 | 1 | 1 | 0.0% |
07 / Top Product and Service Codes
What products and services does the government buy from this vendor?
| PSC | Description | Obligations | Actions | Customers | Share |
|---|---|---|---|---|---|
| 6640 | LABORATORY EQUIPMENT AND SUPPLIES | $456.2K | 27 | 4 | 21.5% |
| 6515 | MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $399.8K | 2 | 1 | 18.8% |
| 6505 | DRUGS AND BIOLOGICALS | $387.4K | 26 | 1 | 18.2% |
| Q301 | MEDICAL- LABORATORY TESTING | $364.4K | 17 | 1 | 17.2% |
| 6550 | IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $272.2K | 13 | 3 | 12.8% |
| 6810 | CHEMICALS | $149.7K | 12 | 1 | 7.1% |
| 6509 | DRUGS AND BIOLOGICALS, VETERINARY USE | $94.4K | 4 | 1 | 4.4% |
| R499 | SUPPORT- PROFESSIONAL: OTHER | -$600 | 1 | 1 | 0.0% |
08 / Competition Pattern
How was ADVANCED CELL DIAGNOSTICS, INC.’s federal work competed?
Competition categories describe the procurement path recorded on the underlying contract actions.
09 / Recent Contract Awards
What contract actions were recorded most recently for ADVANCED CELL DIAGNOSTICS, INC.?
The latest recorded PIIDs connect this profile to the underlying federal award search.
| Award / PIID | Signed | Obligation | Agency / office | NAICS | PSC |
|---|---|---|---|---|---|
| HHSF223201610487P | Aug 14, 2026 | -$2.1K | FOOD AND DRUG ADMINISTRATION FDA OFFICE OF ACQ GRANT SVCS | 541711 | 6550 |
10 / Interpreting the Profile
How should you evaluate ADVANCED CELL DIAGNOSTICS, INC. as a federal contractor?
Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.
Separate obligations from revenue
FPDS obligations are government accounting actions and may include later deobligations.
Follow customer concentration
Agency and office concentration reveals where the vendor’s federal relationships are strongest.
Test market overlap
NAICS and PSC shares show whether the vendor competes in the same markets as your company.
Inspect the awards
Open the PIIDs to verify dates, offices, classifications, and transaction history.